Observational studyJournal of the American Heart Association2020

Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.

Maarit J Korhonen, Jaana Pentti, Juha Hartikainen, Jenni Ilomäki, Soko Setoguchi, Danny Liew, Mika Kivimäki, Jussi Vahtera

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2020. The graph read 1 number from its abstract, feeding 1 cell of the map, but none could be read as for or against, so it casts no vote. Cited by 17 papers, 1 of them a synthesis that pooled it.

1number the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

Read, but not usablea number the graph found but could not read as for or against

Body weight & compositioncomparator not stated · hypertension, ascvdfeeds one cell of the map
Δ 0.190.16 to 0.22
In participants who initiated medication use, body mass index increased more (difference in change 0.19; 95% CI, 0.16-0.22) and physical activity declined (-0.09 metabolic equivalent of task hour/day; 95% CI, -0.16 to -0.02) compared with noninitiators.

clause the extractor read what became the number

2 · Its place on the map

Where it lands on the map

Rows are treatments, columns are outcomes. The coloured squares are the cells this paper feeds, coloured by the vote it casts there. Click one to jump to what this paper adds to it.

supports the treatmentfavours the comparatorno clear differenceread, but no usable result
3 · What it changes

What it adds to each cell

For every cell the paper feeds: the belief in the claim with and without this paper, and this paper's estimate drawn against every other readable study in the cell. The ringed dot is this paper.

Diet, exercise & lifestyle×body weight & composition

No readable resultOpen on the map →What to test next →

3 readable studies in this cell: 2 favour the treatment, 0 find no difference, 1 favour the comparator.

Belief with this paper
0.12contested · 1 family supports, 2 contradict · against placebo
Without itNot a counted family in this claim, so removing it changes nothing.
← favours the treatmentfavours the comparator →
0 · no effect
Δ -5.40-9.00 to -1.70
estimated mean change 7.034.25 to 9.80

This paper's own estimate is on a different scale from the rest of the cell, so it is not drawn here.

4 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

5 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
6 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

7 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Maarit J KorhonenDepartment of Public Health University of Turku Finland.
Jaana PenttiFinnish Institute of Occupational Health Helsinki Finland.
Juha HartikainenHeart Center Kuopio University Hospital Kuopio Finland.
Jenni IlomäkiCentre for Medicine Use and Safety Faculty of Pharmacy and Pharmaceutical Sciences Monash University Melbourne Victoria Australia.
Soko SetoguchiRutgers School of Public Health and Rutgers Robert Wood Johnson Medical School New Brunswick NJ.
Danny LiewSchool of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia.
Mika KivimäkiFinnish Institute of Occupational Health Helsinki Finland.
Jussi VahteraDepartment of Public Health University of Turku Finland.
Finnish Institute of Occupational Health · FIMonash University · AUUniversity of Turku · FIJohnson University · USKuopio University Hospital · FI

Funding

Medical Research Council MR/K013351/1
8 · The paper itself

Abstract

The marked sentences are the ones the graph read a number from.

Background Lifestyle modification is a key component of cardiovascular disease prevention before and concurrently with pharmacologic interventions. We evaluated whether lifestyle factors change in relation to the initiation of antihypertensive or lipid-lowering medication (statins). Methods and Results The study population comprised 41 225 participants of the FPS (Finnish Public Sector) study aged ≥40 years who were free of cardiovascular disease at baseline and responded to ≥2 consecutive surveys administered in 4-year intervals in 2000-2013. Medication use was ascertained through pharmacy-claims data. Using a series of pre-post data sets, we compared changes in body mass index, physical activity, alcohol consumption, and smoking between 8837 initiators and 46 021 noninitiators of antihypertensive medications or statins. In participants who initiated medication use, body mass index increased more (difference in change 0.19; 95% CI, 0.16-0.22) and physical activity declined (-0.09 metabolic equivalent of task hour/day; 95% CI, -0.16 to -0.02) compared with noninitiators. The likelihood of becoming obese (odds ratio: 1.82; 95% CI, 1.63-2.03) and physically inactive (odds ratio: 1.08; 95% CI, 1.01-1.17) was higher in initiators. However, medication initiation was associated with greater decline in average alcohol consumption (-1.85 g/week; 95% CI, -3.67 to -0.14) and higher odds of quitting smoking (odds ratio for current smoking in the second survey: 0.74; 95% CI, 0.64-0.85). Conclusions These findings suggest that initiation of antihypertensive and statin medication is associated with lifestyle changes, some favorable and others unfavorable. Weight management and physical activity should be encouraged in individuals prescribed these medications.

Indexed as

Healthy LifestylePrimary PreventionRisk Reduction BehaviorAdultAntihypertensive AgentsBiomarkersBlood PressureCardiovascular DiseasesDyslipidemiasFemaleFinlandHeart Disease Risk FactorsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionLipidsAntihypertensive AgentsBiomarkersHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsantihypertensive agentslifestylelongitudinalprimary preventionstatins

Identifiers

PMID32019405
PMCPMC7070189
OpenAlexW3004716988

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.